Correlations between impairment, psychological distress, disability, and quality of life in peripheral facial palsy

Autor: Díaz-Aristizabal, U., Valdés-Vilches, M., Fernández-Ferreras, T.R., Calero-Muñoz, E., Bienzobas-Allué, E., Moracén-Naranjo, T.

Publikováno v: In Neurología (English Edition) September 2019 34(7):423-428

Novel surface modification of three-dimensional bacterial nanocellulose with cell-derived adhesion proteins for soft tissue engineering

Autor: Osorio, M., Ortiz, I., Gañán, P., Naranjo, T., Zuluaga, R., van Kooten, T.G., Castro, C.

Publikováno v: In Materials Science & Engineering C July 2019 100:697-705

Threatened Birds of the Americas. N. J. Collar L. P. Gonzaga N. Krabbe A. Madrono Nieto L. G. Naranjo T. A. Parker III D. C. Wege

Autor: Robinson, Scott K.

Publikováno v: The Quarterly Review of Biology, 1994 Jun 01. 69(2), 281-282.

Externí odkaz: https://www.jstor.org/stable/3037767

Análisis de los factores que influyen en la afectación psicológica, la capacidad funcional y la calidad de vida en pacientes con parálisis facial periférica

Autor: Díaz-Aristizabal, U., Valdés-Vilches, M., Fernández-Ferreras, T.R., Calero-Muñoz, E., Bienzobas-Allué, E., Moracén-Naranjo, T.

Publikováno v: In Rehabilitación April-June 2017 51(2):73-78

CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.

Autor: Hontecillas-Prieto L; Clinical Biochemistry Service, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain., García-Domínguez DJ; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain., Palazón-Carrión N; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain., Martín García-Sancho A; Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain., Nogales-Fernández E; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain., Jiménez-Cortegana C; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain., Sánchez-León ML; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain., Silva-Romeiro S; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain., Flores-Campos R; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain., Carnicero-González F; Department of Hematology, Hospital San Pedro de Alcántara de Cáceres, Cáceres, Spain., Ríos-Herranz E; Department of Hematology, Hospital Universitario de Valme, Seville, Spain., de la Cruz-Vicente F; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville, Spain., Rodríguez-García G; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville, Spain., Fernández-Álvarez R; Department of Hematology, Cabueñes Hospital, Gijón, Spain., Martínez-Banaclocha N; Oncology Dept., Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Gumà-Padrò J; Department of Clinical Oncology, Hospital Universitari Sant Joan de Reus URV, IISPV, Reus, Spain., Gómez-Codina J; Department of Clinical Oncology, Hospital Universitario La Fé, Valencia, Spain., Salar-Silvestre A; Department of Hematology, Hospital del Mar, Barcelona, Spain., Rodríguez-Abreu D; Department of Clinical Oncology, Hospital Universitario Insular, Las Palmas de Gran Canaria, Spain., Gálvez-Carvajal L; Department of Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Labrador J; Department of Hematology, Research Unit, Hospital Universitario de Burgos, Burgos, Spain., Guirado-Risueño M; Department of Clinical Oncology, Hospital General Universitario de Elche, Elche, Spain., Provencio-Pulla M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain., Sánchez-Beato M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, CIBERONC, Madrid, Spain., Marylene L; Department of Pathology, Plataforma de Estudios Histológicos, Citológicos y de Digitalización, Hospital de Tortosa Verge de la Cinta, IISPV, URV, Tortosa, Tarragona, Spain., Álvaro-Naranjo T; Department of Pathology, Hospital de Tortosa Verge de la Cinta, Catalan Institute of Health, Institut d'Investigació Sanitària Pere Virgili (IISPV), Tortosa, Tarragona, Spain., Casanova-Espinosa M; Department of Hematology/Clinical Oncology, Hospital Costa del Sol, Marbella, Spain., Rueda-Domínguez A; Department of Hematology/Clinical Oncology, Hospital Costa del Sol, Marbella, Spain., Sánchez-Margalet V; Clinical Biochemistry Service, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain., de la Cruz-Merino L; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Feb 26; Vol. 15, pp. 1293931. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).